Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Vigorous physical activity may preserve cognitive function in high-risk HTN
Jun 24, 2024
High versus low vigorous physical activity was linked to a lower risk of mild cognitive impairment, probable dementia and MCI/probable dementia in a multivariate model.
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.
Tau PET performs well in predicting dementia in individuals with MCI
Jun 12, 2024
Tau positron emission tomography predicts all-cause dementia and Alzheimer disease dementia
Self-, partner-reported cognitive decline linked to tau
May 30, 2024
Significant associations were seen between self- and study partner-reported Cognitive Function Index and tau driven by elevated Aβ.
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Missed, undiagnosed cirrhosis may be risk factor for cognitive decline
Feb 02, 2024
More than 5% of veterans with dementia had a Fibrosis-4 score greater than 3.25, suggestive of cirrhosis.
Cognitive deficits seen in COVID-19 patients regardless of symptom duration
Feb 29, 2024
Compared with those without COVID-19, similar deficits were seen for those in whom symptoms resolved in less than four or at least 12 weeks.
Healthier lifestyle linked to better global cognition close to death
Feb 06, 2024
Neither the strength nor the significance of the association was changed when common dementia-related brain pathologies were included in the model.